… Food and Drug Administration (FDA) has given Rocket Pharmaceuticals approval to … the treatment regimen, which Rocket incorporated into the trial … alleging that the biotech hid key safety issues … This includes the use of Rapamune (sirolimus), rituximab and …

… often progresses to colorectal cancer without intervention. The subjects … for the study. Biodexa Pharmaceuticals CFO and CEO Stephen … under the brand name Rapamune by Pfizer. eRapa leverages … common with existing rapamycin treatments. The drug is supported by …

… for Medicine. For more information about the Serenta trial, … transplantation as Rapamune®(Pfizer). Through the … contact: About Biodexa Pharmaceuticals PLC Biodexa Pharmaceuticals PLC (listed on … Bladder Cancer; tolimidone, under development for the treatment of …

… Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC … to colorectal cancer. The only current treatment option is … Designation by the FDA, Orphan Drug designation in Europe … in renal transplantation as Rapamune®. Through the use …

Biodexa Pharmaceuticals, a clinical stage … products for the treatment of diseases with unmet medical needs, announced … adenomatous polyposis typically leads to cancer of the colon and… rejection in renal transplantation as Rapamune (Pfizer). Through the use …

… Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC … in renal transplantation as Rapamune®(Pfizer). Through the … Bladder Cancer; tolimidone, under development for the treatment of … and is activated during tumorigenesis. Tolimidone is an …

… Inc. – Xeljanz (tofacitinib), Rapamune (sirolimus) Merck – Pred … and other medications are often more … presence of key pharmaceutical and biotechnology companies. High … Trial Trends and Drug Development Pipeline 6. Competitive Landscape 7. Uveitis Treatment …

… ended June 30, 2025 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), … for the treatment of diseases with unmet medical needs, today … Serenta trial by the Pan American Center for Oncology Trials … Invasive Bladder Cancer (“NMIBC”) NMIBC refers to tumors found in …

… currently no pharmaceutical intervention. ” This Orphan Drug Designation … renal transplantation as Rapamune®(Pfizer). Through the … Bladder Cancer; tolimidone, under development for the treatment of … is activated during tumorigenesis. Tolimidone is an …

… in Australia prescribed him Rapamune, a formulation of … Felycin contains rapamycin, a medication with a variety of applications … the drug, which also is being investigated as a cancer treatment. … Miller followed the Felycin trial study with interest. Once …